NG
EW icon

Norden Group’s Edwards Lifesciences EW Stock Holding History

Norden Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Sell
2,396
-460
-16% -$38.5K 0.02% 640
2026
Q1 		$229K Buy
+2,856
New +$235K 0.02% 546

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Norden Group's EW Position: Q2 2026 in Review

Norden Group reduced its Edwards Lifesciences (EW) stake by 16% in Q2 2026, selling an estimated $38.5K and leaving 2,396 shares worth $217K. The position accounts for 0.02% of the portfolio, ranked #640.

Norden Group first reported a position in EW in Q1 2026 and has held it in 2 quarters since. The position peaked at $229K in Q1 2026. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Norden Group held 2,396 shares of Edwards Lifesciences worth $217K as of Q2 2026.
  • Norden Group sold 460 Edwards Lifesciences shares in Q2 2026, an estimated $38.5K.
  • Edwards Lifesciences made up 0.02% of Norden Group's portfolio in Q2 2026, its #640 holding.
  • Norden Group first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
  • Norden Group's Edwards Lifesciences position peaked at $229K in Q1 2026.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.